NASDAQ NMS - GLOBAL MARKET · INM
+2.12% · +$0.0303 · Vol Not reported
Pre-market · updated 07:34:55 ET
InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc

Pharmaceuticals
$1.46
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
INM
InMed Pharmaceuticals Inc
Mon Aug 24 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

50/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Mon Aug 24 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INM catalysts
About InMed Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
13
Country
CA

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.43
Last session
Day high
$1.43
Last session
Day low
$1.43
Last session
Previous close
$1.43
52W high
$2.46
-40.64% from high
52W low
$0.6150
46% of range
Market cap
$4.7M
EPS
$-3.6200
Beta
-1.35
Shares out
5.3M
Avg volume
1.9M
VWAP
$1.43
Last session
Price history computed in-house
1W
+1.41%
1M
-14.60%
3M
-12.03%
1Y
-34.52%
YTD
+37.76%
SMA 50 $1.54 · below
SMA 200 $1.19 · above
52W position 46%

INM overview

Veridion Score
50
Registered · 2026-08-24
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around INM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading INM Form 4 filings
Public disclosures

Congress activity in INM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for INM in the cached public ledger.

Federal contracts

INM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INM in this window.
Lobbying spend

INM lobbying filings, year to date.

Registered lobbying filings matched to InMed Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INM in this window.
Loading news for INM
Analyst ratings
Sovereign unlock shows live analyst consensus for INM.
Options
Sovereign unlock shows live options positioning for INM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.